Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma
Clinical trial NCT05508399 · COMPLETED
Trial details
- NCT number
- NCT05508399
- Sponsor
- Xijing Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-18
- Primary completion
- 2024-01-10
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.